Published in Proc Soc Exp Biol Med on March 01, 1951
Stress and the general adaptation syndrome. Br Med J (1950) 5.07
Further studies concerning the participation of the adrenal cortex in the pathogenesis of arthritis. Br Med J (1949) 4.53
Use of granuloma pouch technic in the study of antiphlogistic corticoids. Proc Soc Exp Biol Med (1953) 3.36
Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology (1960) 3.24
On the mechanism through which hydrocortisone affects the resistance of tissues to injury; an experimental study with the granuloma pouch technique. J Am Med Assoc (1953) 2.54
Excessive stimulation of salivary gland growth by isoproterenol. Science (1961) 2.33
Provocation and prevention of potassium deficiency by various ions. Proc Soc Exp Biol Med (1958) 2.27
The influence of STH, ACTH and cortisone upon resistance to infection. Can Med Assoc J (1951) 1.89
Effect of ACTH and cortisone upon an anaphylactoid reaction. Can Med Assoc J (1949) 1.88
The general adaptation syndrome and the diseases of adaptation. J Clin Endocrinol Metab (1946) 1.82
Role of local trauma in production of cutaneous calcinosis by dihydrotachysterol. Proc Soc Exp Biol Med (1960) 1.78
Anticortisol action of aldosterone. Science (1955) 1.70
On the participation of the reticulo-endothelial system in the alarm reaction. Science (1949) 1.64
HISTOCHEMICAL STUDIES ON THE ROLE OF THE MAST CELL IN CALCERGY. J Histochem Cytochem (1964) 1.63
Stress and disease. Science (1955) 1.61
Adrenocorticotrophic effect of stress after severance of the hypothalamo-hypophyseal pathways. Am J Physiol (1949) 1.57
Lathyrism. Rev Can Biol (1957) 1.50
Anticortisol action of 2-methyl-9-(alpha)-fluorocortisol. Proc Soc Exp Biol Med (1956) 1.49
On the anticatabolic and anticalcinotic effects of 17-ethyl-19-nortestosterone. Am J Med Sci (1958) 1.39
Rheumatic diseases as diseases of adaptation. Br Med J (1950) 1.25
Experimental production of endomyocardial fibrosis. Lancet (1958) 1.20
Effect of denervation on experimentally induced changes in the growth of bone and muscle. Am J Physiol (1958) 1.19
The general adaptation syndrome and the diseases of adaptation. Practitioner (1949) 1.14
Participation of brown fat tissue in the alarm reaction. Nature (1949) 1.14
Inflammation as influenced by a topical blockade of the reticulo-endothelial system; an example of local crossed sensitisation. Br J Exp Pathol (1953) 1.11
An electrolyte-steroid cardiopathy with calcification (ESCC). Acta Cardiol (1960) 1.10
Limitations of the ACTH regulating effect of corticoids. Am J Physiol (1951) 1.08
Calciphylaxis in relation to the humoral production of occlusive coronary lesions with infarction. J Pathol Bacteriol (1962) 1.07
Cutaneous molt induced by calciphylaxis in the rat. Science (1961) 1.06
[Role of the adrenal cortex in the pathogenesis of various vascular changes]. Munch Med Wochenschr (1956) 1.06
Sensitization to calciphylaxis by endogenous parathyroid hormone. Endocrinology (1962) 1.05
Hormonally induced transformation of adrenal into myeloid tissue. Am J Pathol (1950) 1.05
Adaptive reaction to stress. Psychosom Med (1950) 1.03
[Humoral influences in experimental lathyrism]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1957) 1.02
Calcinosis induced by lead acetate. J Pharmacol Exp Ther (1962) 1.01
On the role of adjuvants in calciphylaxis. Rev Allergy (1961) 1.00
Prevention of the phosphate-steroid-cardiopathy by various electrolytes. Am Heart J (1958) 1.00
PROTECTION BY VARIOUS ANABOLIC STEROIDS AGAINST DIHYDROTACHYSTEROL INDUCED CALCINOSIS AND CATABOLISM. Acta Endocrinol (Copenh) (1965) 0.99
Effect of corticoids upon the resistance of the kidney to sublimate intoxication. J Lab Clin Med (1957) 0.99
Humoral conditioning for production of acute, massive myocardial necroses by neuromuscular exertion. Proc Soc Exp Biol Med (1957) 0.98
Adaptation to the cardiac necrosis-eliciting effect of stress. Am J Physiol (1960) 0.94
Influence of cold, fasting and adrenalectomy on the blood-fibrinogen response to trauma. Proc Soc Exp Biol Med (1950) 0.93
Thyroxin as sensitizing agent in production of renal and cardiovascular lesions with corticoids. Proc Soc Exp Biol Med (1956) 0.93
Role of somatotrophic hormone in the production of malignant nephrosclerosis, periarteritis nodosa, and hypertensive disease. Br Med J (1951) 0.92
Production of an electrolyte-steroid cardiopathy with NaClO4 and its prevention by MgCl2 and KCl. Angiology (1958) 0.92
Influence of variations in dietary intake of chlorides upon diverse necrotizing cardiopathies. Am Heart J (1960) 0.92
EXPERIMENTAL PRODUCTION OF PARATHYROID CYSTS. Am J Pathol (1964) 0.92
[Production of a heart infarction in several animal species]. Gaz Med Port (1958) 0.91
Protection, by coronary ligature, against isoproterenol-induced myocardial necroses. Proc Soc Exp Biol Med (1960) 0.91
Influence of sodium chloride upon the actions of desoxycorticosteron acetate. Am Heart J (1949) 0.91
[Interrelationships between stress, electrolytes and steroids in the patheogenesis of various cardiopathies and myopathies]. Endokrinologie (1959) 0.91
The general-adaptation-syndrome. Annu Rev Med (1951) 0.91
[Induction and prevention of cardiac necroses in the dihydrotachysterin-sensitized rat]. Virchows Arch (1959) 0.90
Organ lesions produced by hexadimethrine and their modification by various agents. Med Exp Int J Exp Med (1963) 0.90
[Induction of fibrous osteodystrophy by calciphylaxis]. Beitr Pathol Anat (1961) 0.90
Influence of inoculation site upon the course of the anaphylactoid reaction to dextran. J Allergy (1954) 0.90
Effect of corticoids upon skeletal and renal changes produced by stylomycin aminonucleoside. Proc Soc Exp Biol Med (1957) 0.90
Production of calciphylactic facial, oesophageal, and mediastinal lesions by combined treatment with dihydrotachysterol and thorium dioxide. Br Med J (1961) 0.90
On extra-adrenal actions of adrenocorticotrophic preparations. Endocrinology (1952) 0.90
Prophylactic treatment of an experimental arteriosclerosis with magnesium and potassium salts. Am Heart J (1958) 0.89
The role of the thyroid in the production of cardiovascular and renal changes by methylandrostenediol. J Endocrinol (1954) 0.89
Induction by aminoacetonitrile of a predisposition to giant callus formation. Br J Exp Pathol (1957) 0.89
Experimental production of cutaneous calcinosis and sclerosis with dihydrotachysterol (AT-10). J Invest Dermatol (1957) 0.89
Effect of STH on experimental lathyrism. Proc Soc Exp Biol Med (1957) 0.88
On the anti-inflammatory action of aminoacetonitrile (AAN). Can J Biochem Physiol (1957) 0.88
[Effects of local factors on the pathogenesis of renal calculi & tissue calcifications]. Z Urol (1957) 0.88
Experimental production of cholangitis and pancreatitis by ferric oxide saccharate (Fe-OS). Am J Gastroenterol (1962) 0.87
The hormonal production of nephrosclerosis and periarteritis nodosa in the primate. Br Med J (1957) 0.87
[A THROMBOHEMORRHAGIC PHENOMENON INDUCED BY DIFFERENT AGENTS]. Allerg Asthma (Leipz) (1964) 0.87
The stress concept in 1955. J Chronic Dis (1955) 0.87
Screening of possible therapeutic agents by means of experimental replicas of connective-tissue diseases. Ann N Y Acad Sci (1956) 0.86
On the structural changes produced in the brain and hypophysis by parenteral administration of highly hypertonic solutions. Acta Anat (Basel) (1952) 0.86
CALCIPHYLAXIS AND THE PARATHYROID GLANDS. Recent Prog Horm Res (1964) 0.86
Protection by a steroid-spirolactone against certain types of cardiac necroses. Proc Soc Exp Biol Med (1960) 0.85
Pathogenesis of the cardiovascular and renal changes which usually accompany malignant hypertension. J Urol (1946) 0.85
The effect of topically administered hydrocortisone upon dystrophic skin, as revealed by the pneumoderma technic. J Invest Dermatol (1953) 0.85
Production of hypertension and hyalinosis by desoxocortisone. Br Med J (1950) 0.85
The production of hypertension, nephrosclerosis and cardiac lesions by methylandrostenediol treatment in the rat. Endocrinology (1954) 0.84
Inhibition by hypophysectomy of organ lesions normally produced by parathyroid hormone or dihydrotachysterol. Lab Invest (1962) 0.84
Prevention by stress and cortisol of gastric ulcers normally produced by 48/80. Proc Soc Exp Biol Med (1960) 0.84
A calcifying cardiopathy produced by stress and calcium acetate. Br J Exp Pathol (1961) 0.84
[Protective effect of hypophysectomy against an experimental nephrocalcinosis]. Endokrinologie (1958) 0.84
Sensitization of the skeleton to vitamin-A overdosage by cortisol. Arthritis Rheum (1958) 0.83
Effect of corticoids upon experimental lathyrism. Endocrinology (1957) 0.83
Conditioning by corticoids for the production of cardiac lesions with noradrenaline. Acta Endocrinol (Copenh) (1959) 0.83
Prevention of cortisone overdosage effects with the somatotrophic hormone (STH). Am J Physiol (1952) 0.83
Stress and psychiatry. Am J Psychiatry (1956) 0.82
Participation of ovarian hormones in the development of nephrocalcinosis. Gynaecologia (1958) 0.82
Production by various fats of myocardial necroses in humorally conditioned rats. Proc Soc Exp Biol Med (1958) 0.82
[Comparison between the anti-inflammatory action of cortisone and of the phenergan-irgapyrine combination on experimental arthritis]. Rev Can Biol (1952) 0.82
Abnormal growth and sclerosis of the salivary glands induced by chronic treatment with isoproterenol. Growth (1961) 0.82
Prevention by somatotrophin of the catabolism which normally occurs during stress. Endocrinology (1951) 0.82
[Production of hypertension and malignant nephrosclerosis by thyroxin in the rat]. Rev Can Biol (1951) 0.82
Sensitization by potassium deficiency for the production of myocardial necrosis by stress. Am J Pathol (1959) 0.82
Protection by anti-mineralocorticoid against an otherwise fatal dihydrotachysterol intoxication. Lancet (1960) 0.82
Factors that determine the production of cardiovascular and renal lesions by polymyxin. Antibiot Chemother (Northfield) (1961) 0.81
[Experimental studies on the effect of adaptation hormones (STH, cortisol) on transplantable tumors]. Z Krebsforsch (1955) 0.81
Hormonal factors in the production of experimental renal and cardiovascular disease; synergism between somatotrophic hormone and methylandrostenediol. J Lab Clin Med (1955) 0.81
Interactions between gluco-corticoid and mineralo-corticoid hormones. J Clin Invest (1950) 0.81
What is stress? Metabolism (1956) 0.81